计算溶液所需的质量、体积或浓度。
Benralizumab (anti-IL-5Ra) (Ab175469) - ELISA
Immobilized huIL-5Rα-his at 2.0 μg/mL can bind Benralizumab (anti-IL-5Ra) (Ab175469) with the EC₅₀ of 16.39 ng/mL.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| Ab175469-100μg |
100μg |
现货 ![]() |
| |
| Ab175469-1mg |
1mg |
现货 ![]() |
| |
| Ab175469-5mg |
5mg |
现货 ![]() |
| |
| Ab175469-10mg |
10mg |
期货 ![]() |
|
| 产品名称 | Benralizumab (anti-IL-5Ra), 白细胞介素 5 受体 α 亚基抗体 |
|---|---|
| 别名 | 贝那利珠单抗 | 贝那利珠单抗(抗 IL-5Ra) |
| 英文别名 | CD125 antibody | CD125 antigen antibody | CDw125 antibody | HSIL5R3 antibody | IL-5 receptor subunit alpha antibody | IL-5R subunit alpha antibody | IL-5R-alpha antibody | IL-5RA antibody | IL5R antibody | IL5RA antibody | IL5RA_HUMAN antibody | Interleuk |
| 规格或纯度 | 无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
| 宿主种属 | 人(Human) |
| 特异性 | IL5RA |
| 种属反应性 | 人(Human),兔(Rabbit),大鼠(Rat),小鼠(Mouse) |
| 偶联 | Unconjugated |
| 作用类型 | 抑制剂 |
| 作用机制 | 白细胞介素 5 受体 α 亚基抗体 |
| 克隆类型 | 重组抗体 |
|---|---|
| Format | Whole IgG |
| 亚型 | Human IgG1 |
| 轻链亚型 | kappa |
| SDS-PAGE | 26.9 kDa (Light Chain) & 52.8 kDa (Heavy Chain), under reducing conditions; 193.8 kDa, under non-reducing conditions. |
| 纯化方法 | Protein A purified |
| 纯度 | >95% |
| 物理外观 | Liquid |
| 储存缓冲液 | Supplied as a 0.22μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0 |
| 防腐剂 | No |
| 浓度 | 见COA |
| 储存温度 | -80℃储存,避免反复冻融 |
| 运输条件 | 超低温冰袋运输 |
| 稳定性与储存 | 在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。 |
| CAS编号和信息 | 1044511-01-4 |
| 分子类型 | 抗体 |
Benralizumab (anti-IL-5Ra) (Ab175469) - ELISA
Immobilized huIL-5Rα-his at 2.0 μg/mL can bind Benralizumab (anti-IL-5Ra) (Ab175469) with the EC₅₀ of 16.39 ng/mL.
Benralizumab (anti-IL-5Ra) (Ab175469) - SEC
The purity of Benralizumab (anti-IL-5Ra) (Ab175469) is more than 95% verified by HPLC.
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 日期 | 货号 |
|---|---|---|---|
| 分析证书 | 24-03-29 | Ab175469 | |
| 分析证书 | 24-03-29 | Ab175469 | |
| 分析证书 | 24-03-29 | Ab175469 |
| 1. Ghazi A, Trikha A, Calhoun WJ. (2012) Benralizumab--a humanized mAb to IL-5Rα with enhanced antibody-dependent cell-mediated cytotoxicity--a novel approach for the treatment of asthma.. Expert Opin Biol Ther, 12 (1): (113-8). [PMID:22136436] |
| 2. FitzGerald JM, Bleecker ER, Nair P, Korn S, Ohta K, Lommatzsch M, Ferguson GT, Busse WW, Barker P, Sproule S et al.. (2016) Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial.. Lancet, 388 (10056): (2128-2141). [PMID:27609406] |
| 3. Castro M, Wenzel SE, Bleecker ER, Pizzichini E, Kuna P, Busse WW, Gossage DL, Ward CK, Wu Y, Wang B et al.. (2014) Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study.. Lancet Respir Med, 2 (11): (879-90). [PMID:25306557] |
| 4. Mukherjee M, Sehmi R, Nair P. (2014) Anti-IL5 therapy for asthma and beyond.. World Allergy Organ J, 7 (1): (32). [PMID:25709744] |
| 5. Morokata T, Ida K, Yamada T. (2002) Characterization of YM-90709 as a novel antagonist which inhibits the binding of interleukin-5 to interleukin-5 receptor.. Int Immunopharmacol, 2 (12): (1693-702). [PMID:12469943] |
| 6. Tavernier, J J and 5 more authors.. (1992) Molecular basis of the membrane-anchored and two soluble isoforms of the human interleukin 5 receptor alpha subunit.. Proceedings of the National Academy of Sciences of the United States of America, (1): [PMID:1495999] |
| 7. Murata, Y Y and 5 more authors.. (1992) Molecular cloning and expression of the human interleukin 5 receptor.. The Journal of experimental medicine, (1): [PMID:1732409] |
| 8. Tavernier, J J and 6 more authors.. (1991) A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific alpha chain and a beta chain shared with the receptor for GM-CSF.. Cell, (20): [PMID:1833065] |
| 9. Monahan, J J and 13 more authors.. (1997) Attenuation of IL-5-mediated signal transduction, eosinophil survival, and inflammatory mediator release by a soluble human IL-5 receptor.. Journal of immunology (Baltimore, Md. : 1950), (15): [PMID:9378992] |
| 10. Ogata, N N and 6 more authors.. (1998) JAK2 and JAK1 constitutively associate with an interleukin-5 (IL-5) receptor alpha and betac subunit, respectively, and are activated upon IL-5 stimulation.. Blood, (1): [PMID:9516124] |
| 11. Muzny, Donna M DM and 113 more authors.. (2006) The DNA sequence, annotation and analysis of human chromosome 3.. Nature, (27): [PMID:16641997] |
| 12. Patino, Edwin E and 6 more authors.. (2011) Structure analysis of the IL-5 ligand-receptor complex reveals a wrench-like architecture for IL-5Rα.. Structure (London, England : 1993), (7): [PMID:22153509] |
| 13. Kusano, Seisuke S and 10 more authors.. (2012) Structural basis of interleukin-5 dimer recognition by its α receptor.. Protein science : a publication of the Protein Society, [PMID:22528658] |
| 14. Laviolette, Michel and 11 more authors.. (2013) Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia.. The Journal of allergy and clinical immunology, [PMID:23866823] |
| 15. Bagnasco, Diego D and 5 more authors.. (2017) Anti-Interleukin 5 (IL-5) and IL-5Ra Biological Drugs: Efficacy, Safety, and Future Perspectives in Severe Eosinophilic Asthma.. Frontiers in medicine, [PMID:28913336] |